-
Two days before a panel of experts is set to review Moderna's COVID-19 vaccine and advise the Food and Drug Administration, documents show the vaccine is 94% effective and well-tolerated.
-
The Food and Drug Administration finds "no specific safety concerns" that would stand in the way of authorization of the vaccine for emergency use. Effectiveness is 95% after two doses.
-
The vaccine was found to be 95% effective in an updated study analysis. Safety data required by the Food and Drug Administration showed no serious concerns, the company said.
-
Central State University in Wilberforce has received a $1.3 million hemp research contract from the United States Food and Drug Administration.Central…
-
The Food and Drug Administration says it still needs more information from Columbus research firm Battelle about how it would respond to "adverse events"…
-
A Senate hearing on the coronavirus pandemic follows the day after the U.S. death toll from the coronavirus pandemic topped 200,000 people. The session is underway now.
-
The Food and Drug Administration's chief said Sunday the therapy reduces deaths among COVID-19 patients by 35%. On Monday he apologized, acknowledging that statistic greatly exaggerates any benefit.
-
Ali Schroer was just out of college when she started her first teaching job, but her new insurance plan didn’t cover her allergy medication. "So this...
-
Emergency use authorization makes it easier for doctors to use a drug in a manner not specifically approved by the Food and Drug Administration. The FDA granted these drugs this status in March.
-
Reproductive rights advocates want patients to be allowed to pick up mifepristone at a hospital or clinic. The drug, which was approved 20 years ago, also helps to manage miscarriages for some women.